Ex-Ante-Transparenzbekanntmachung § 130c Abs. 1 SGB V Arzneimittelbezeichnung Opzelura (R) Wirkstoff: Ruxolitinib ATC-Code: D11AH09

Deadline:N/A

We were not able to find a link to the source, please find contact details in the documents.

Tender information

Germany

Type

Voluntary ex ante transparency

Procedure

Negotiated without a call for competition

Ref. number

26-064

Duration

2 years

Arzneimittelrabattvertrag § 130c Abs. 1 SGB V Arzneimittelbezeichnung Opzelura (R) Wirkstoff: Ruxolitinib ATC-Code: D11AH09

Buyer

AOK Bayern - Die Gesundheitskasse

Documents

Document name	Upload date	File size
First document.pdf	1 Jan 1970, 00:00	1 Bytes
Second document.pdf	1 Jan 1970, 00:00	1 Bytes

Information on this page originates from the following sources: TED

Buyer

AOK Bayern - Die Gesundheitskasse

No time limit

Important dates

22 Jun - Publication date

Unlock Full Access with Mercell Bidding Business Plus

Start your free trial to explore exclusive features that help you win more tenders, faster:

AI-Powered Tender Insights

Buyer Contact Info

Key Tender Timelines

Already have an account?

We were not able to find a link to the source, please find contact details in the documents.